฿0
+฿0(0.00%)
No data
data.updated
v2.stock.overview v2.daily.trading v2.range.52w
key.stats
yesterday.close฿30
market.size฿36.39B
volume.trade6.97M
pe.ratio25.43
div.yield0.00%
div.amount฿0
diluted.eps1.23
net.income฿1.41B
revenue฿17.25B
earnings.date2026-04-29
eps.estimate0.50
rev.estimate฿3.78B
shares.out1.18B
beta0.764
ex.div.date2017-11-27
div.pay.date2017-12-12
about.stock
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
sectorHealthcare
industryDrug Manufacturers - Specialty & Generic
ceoRichard D. Francis
headquartersTel Aviv,None,IL
websitehttps://www.tevapharm.com
employees34.00K
avg.revenue฿507.55K
income.per.emp฿41.47K
เรียนรู้เพิ่มเติมเกี่ยวกับ Teva Pharmaceutical-Sp (TEVA)
stock.faq
stock.price
x
current.stats
52w.range.q
x
pe.ratio.q
x
market.cap.q
x
eps.recent.q
x
buy.sell.q
x
price.factors
x
buy.how
x
risk.warn
risk.notice
disclaimer2
risk.disclosure




















































































































































































































































































































































































